Summarizing the above results, this study may provide new ideas and strategies for the treatment of patients with MEN1-mutated tumours and the prevention of MEN1-induced lethality, which are important aims in current research.1 Nevertheless, these studies need to be repeated in other laboratories, and any clinical studies need to be carried out in larger groups of patients, with vigorous controls, possibly using a comparator such as a somatostatin analogue. The gene discussed is MEN1; the disease is neoplasm.